The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta‐analysis

Published:2021-07-19 Issue:10 Volume:100 Page:1788-1799
ISSN:0001-6349
Container-title:Acta Obstetricia et Gynecologica Scandinavica
language:en
Short-container-title:Acta Obstet Gynecol Scand

Author:

Olsen Maria¹,Lof Pien²^ORCID,Stiekema Anna²,Broek Daan³,Wilthagen Erica A.⁴,Bossuyt Patrick M.¹,Lok Christianne A. R.²

Affiliation:

1. Department of Clinical Epidemiology, Biostatistics and Bioinformatics Amsterdam UMC Amsterdam The Netherlands

2. Department of Gynecologic Oncology Center for Gynecologic Oncology Amsterdam The Netherlands Cancer Institute Amsterdam The Netherlands

3. Department of Laboratory Medicine The Netherlands Cancer Institute Amsterdam The Netherlands

4. Scientific Information Service The Netherlands Cancer Institute Amsterdam The Netherlands

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aogs.14224

Reference54 articles.

1. Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands

2. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review

3. CA 125 in Benign Gynecological Conditions

4. Benign conditions associated with raised serum CA-125 concentration

5. Should we centralise care for the patient suspected of having ovarian malignancy?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review;Discover Nano;2024-08-03

2. Is three-dimensional ultrasonography a valuable diagnostic tool for patients with ovarian cancer? Systematic review and meta-analysis;Frontiers in Oncology;2024-07-08

3. Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors;2024-03-15

4. Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer;BMC Women's Health;2024-01-13

5. Expression and Clinical Progress of Tumor Markers CA125, CA199, HE4 and HCG in Ovarian Malignant Tumors;Advances in Clinical Medicine;2024